Caplin
CAPLIPOINT.NSCaplin Point Laboratories Limited Price (CAPLIPOINT.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
76,309,309
(0.258)%Revenue and Profitability
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 377,708,272 | 618,925,771 | 591,187,288 | 607,071,000 | 779,211,508 | 1,072,166,000 | 1,270,283,000 | 1,730,889,000 | 2,517,698,000 | 3,084,480,288 | 4,016,484,000 | 5,398,420,000 | 6,486,909,000 | 8,632,017,000 | 10,482,575,000 | 12,630,100,000 | 14,667,300,000 | 16,767,800,000 |
| Net Income | 14,441,039 | 10,354,523 | 22,257,342 | 33,318,000 | 62,822,792 | 80,065,000 | 139,838,000 | 258,486,000 | 410,369,000 | 609,751,812 | 961,585,000 | 1,447,877,000 | 1,765,670,000 | 2,150,080,000 | 2,422,700,000 | 2,998,400,000 | 3,762,600,000 | 4,570,900,000 |
| FCF USD | 7,103,000 | 1,862,000 | 86,563,000 | -36,134,000 | 73,393,000 | 114,780,000 | -134,439,000 | 83,675,000 | 243,975,000 | 363,555,000 | 422,460,000 | 179,601,000 | 182,434,000 | -320,611,000 | 1,952,894,000 | 2,455,700,000 | 779,000,000 | 1,725,700,000 |
| OCF USD | 20,097,000 | 11,104,000 | 121,665,000 | 2,723,000 | 141,530,000 | 279,243,000 | 319,524,000 | 549,156,000 | 498,827,000 | 446,082,000 | 678,221,000 | 664,815,000 | 834,249,000 | 446,770,000 | 2,657,725,000 | 3,367,500,000 | 2,716,500,000 | 3,183,900,000 |
Financial Health - DEBT
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 8.34 | 2.67 | 2.84 | 1.18 | 0.14 | 0.16 | 0.06 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| D/E | 0.49 | 0.51 | 0.36 | 0.41 | 0.33 | 0.20 | 0.08 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 |
| CA/CL | 1.04 | 1.74 | 1.52 | 1.64 | 1.42 | 0.78 | 0.47 | 0.45 | 0.66 | 1.00 | 1.60 | 2.42 | 5.73 | 5.70 | 7.25 | 6.25 | 5.80 | 5.71 |
| TA/TL | 1.58 | 1.63 | 1.64 | 1.73 | 1.65 | 1.46 | 1.47 | 1.52 | 1.69 | 2.03 | 2.68 | 3.67 | 6.78 | 6.65 | 8.51 | 7.67 | 7.71 | 7.68 |
| Total Debt | 68,474,575 | 109,619,065 | 85,664,229 | 103,704,243 | 97,371,666 | 67,553,000 | 35,371,000 | 21,219,000 | 9,299,000 | 20,036,000 | 7,236,000 | 5,365,000 | 5,412,000 | 386,110,000 | 183,921,000 | 21,300,000 | 52,000,000 | 19,700,000 |
Management Performance
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 5.10% | 2.68% | 6.28% | 11.09% | 10.80% | 16.14% | 24.86% | 197.74% | 39.44% | 35.52% | 36.21% | 34.55% | 24.74% | 20.71% | 20.31% | 20.16% | 19.59% | 24.94% |
| ROE | 10.33% | 4.78% | 9.33% | 13.10% | 21.60% | 23.84% | 32.41% | 41.87% | 44.03% | 45.02% | 42.89% | 39.80% | 27.90% | 22.68% | 20.43% | 20.21% | 20.01% | 19.74% |
| ROA | 0.00% | 2.35% | 5.23% | 6.03% | 11.10% | 10.43% | 16.41% | 19.84% | 23.33% | 22.82% | 33.99% | 37.64% | 30.55% | 23.94% | 23.00% | 22.22% | 20.60% | 16.94% |
| NM % | 3.82% | 1.67% | 3.76% | 5.49% | 8.06% | 7.47% | 11.01% | 14.93% | 16.30% | 19.77% | 23.94% | 26.82% | 27.22% | 24.91% | 23.11% | 23.74% | 25.65% | 27.26% |
| FCF / R% | 0.00% | 0.30% | 14.64% | -5.95% | 9.42% | 10.71% | -10.58% | 4.83% | 9.69% | 11.79% | 10.52% | 3.33% | 2.81% | -3.71% | 18.63% | 19.44% | 5.31% | 10.29% |
| FCF / NI% | 49.19% | 14.17% | 269.87% | -99.04% | 89.23% | 102.74% | -60.72% | 23.44% | 45.70% | 59.62% | 34.69% | 9.53% | 8.04% | -11.90% | 62.27% | 63.65% | 17.26% | 37.75% |
| Operating Margin (OM) | 0.00 | 0.03 | 0.07 | 0.08 | 0.10 | 0.11 | 0.16 | 0.20 | 0.25 | 0.35 | 0.48 | 0.61 | 0.76 | 0.78 | 0.87 | 0.94 | 1.05 | 1.18 |
Per Share
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.22 | 0.14 | 0.29 | 0.44 | 0.83 | 1.06 | 1.85 | 3.42 | 5.43 | 8.07 | 12.73 | 19.16 | 23.35 | 28.42 | 32.03 | 39.61 | 49.62 | 59.90 |
| SPS | 5.81 | 8.19 | 7.83 | 8.04 | 10.31 | 14.19 | 16.81 | 22.91 | 33.32 | 40.83 | 53.16 | 71.43 | 85.80 | 114.12 | 138.58 | 166.85 | 193.43 | 219.74 |
| OCPS | 0.31 | 0.15 | 1.61 | 0.04 | 1.87 | 3.70 | 4.23 | 7.27 | 6.60 | 5.90 | 8.98 | 8.80 | 11.03 | 5.91 | 35.14 | 44.49 | 35.82 | 41.72 |
| FCPS | 0.11 | 0.02 | 1.15 | -0.48 | 0.97 | 1.52 | -1.78 | 1.11 | 3.23 | 4.81 | 5.59 | 2.38 | 2.41 | -4.24 | 25.82 | 32.44 | 10.27 | 22.61 |
| BVPS | 2.15 | 2.86 | 3.16 | 3.37 | 3.85 | 4.45 | 5.72 | 8.20 | 12.37 | 17.96 | 29.72 | 48.15 | 83.72 | 126.46 | 159.08 | 199.46 | 251.52 | 307.54 |
Per Share - CAGR
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.22 | 0.14 | 0.29 | 0.44 | 0.83 | 1.06 | 1.85 | 3.42 | 5.43 | 8.07 | 12.73 | 19.16 | 23.35 | 28.42 | 32.03 | 39.61 | 49.62 | 59.90 |
| CAGR-SPS | 5.81 | 8.19 | 7.83 | 8.04 | 10.31 | 14.19 | 16.81 | 22.91 | 33.32 | 40.83 | 53.16 | 71.43 | 85.80 | 114.12 | 138.58 | 166.85 | 193.43 | 219.74 |
| CAGR-OCPS | 0.31 | 0.15 | 1.61 | 0.04 | 1.87 | 3.70 | 4.23 | 7.27 | 6.60 | 5.90 | 8.98 | 8.80 | 11.03 | 5.91 | 35.14 | 44.49 | 35.82 | 41.72 |
| CAGR-FCPS | 0.11 | 0.02 | 1.15 | -0.48 | 0.97 | 1.52 | -1.78 | 1.11 | 3.23 | 4.81 | 5.59 | 2.38 | 2.41 | -4.24 | 25.82 | 32.44 | 10.27 | 22.61 |
| CAGR-BVPS | 2.15 | 2.86 | 3.16 | 3.37 | 3.85 | 4.45 | 5.72 | 8.20 | 12.37 | 17.96 | 29.72 | 48.15 | 83.72 | 126.46 | 159.08 | 199.46 | 251.52 | 307.54 |